Financhill
Back

Cytokinetics Quote, Financials, Valuation and Earnings

Cytokinetics Price Quote

$48.93
-0.03 (4.69%)
(Updated: December 21, 2024 at 5:22 AM ET)

Cytokinetics Key Stats

Sell
42
Cytokinetics (CYTK) is a Sell

Day range:
$46.85 - $50.32
52-week range:
$43.21 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,627.24
P/B ratio:
61.62%

Volume:
3.5M
Avg. volume:
1.3M
1-year change:
37.07%
Market cap:
$5.8B
Revenue:
$7.5M
EPS:
$-5.38

How Much Does Cytokinetics Make?

Data Unavailable

Is Cytokinetics Growing As A Company?

Data Unavailable

Cytokinetics Stock Price Performance

  • Did Cytokinetics Stock Go Up Last Month?
    Cytokinetics share price went down by -1.81% last month
  • Did CYTK's Share Price Rise Over The Last Year?
    CYTK share price rose by 37.07% over the past 1 year

What Is Cytokinetics 52-Week High & Low?

Cytokinetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cytokinetics?

Data Unavailable

Is Cytokinetics Cash Flow Positive?

Data Unavailable

Cytokinetics Return On Invested Capital

Data Unavailable

Cytokinetics Earnings Date & Stock Price

  • What Is Cytokinetics's Stock Price Today?
    A single share of CYTK can be purchased today for 48.96
  • What Is Cytokinetics’s Stock Symbol?
    Cytokinetics trades on the nasdaq under the ticker symbol: CYTK
  • When Is Cytokinetics’s Next Earnings Date?
    The next quarterly earnings date for Cytokinetics is scheduled on February 27, 2025
  • When Is CYTK's next ex-dividend date?
    Cytokinetics's next ex-dividend date is December 22, 2024
  • How To Buy Cytokinetics Stock?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cytokinetics Competitors

  • Who Are Cytokinetics's Competitors?
    Below is a list of companies who compete with Cytokinetics or are related in some way:
    • Insmed Inc (INSM)
    • Mirum Pharmaceuticals Inc (MIRM)
    • Ocugen Inc (OCGN)
    • Rezolute Inc (RZLT)
    • Scholar Rock Holding Corp (SRRK)

Cytokinetics Dividend Yield

Data Unavailable

Cytokinetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.26%
Revenue: 22.49% -60.77%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 80.69
Upside from Last Price: 64.8%

Major Shareholders

Data Unavailable